2nd Bellwether Jury Says AbbVie Owes AndroGel User $140M
An Illinois federal jury ordered AbbVie Inc. to pay an AndroGel user more than $140 million Thursday after finding the company failed to test its testosterone gel product properly for cardiovascular...To view the full article, register now.
Already a subscriber? Click here to view full article